EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Physiological and pathological functions of LRRK2: implications from substrate proteins

Miho Araki, Genta Ito, Taisuke Tomita iD

Neuronal Signaling · 21.12.2018 · 2 (4)

DOI: 10.1042/ns20180005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neuronal Signaling, online erschienen am 10.10.2018. Verfasst von Miho Araki und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neuropathology and Neuroscience, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113…. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leucine-rich repeat kinase 2 (LRRK2) encodes a 2527-amino acid (aa) protein composed of multiple functional domains, including a Ras of complex proteins (ROC)-type GTP-binding domain, a carboxyl terminal of ROC (COR) domain, a serine/threonine protein kinase domain, and several repeat domains. LRRK2 is genetically involved in the pathogenesis of both sporadic and familial Parkinson’s disease (FPD). Parkinson’s disease (PD) is the second most common neurodegenerative disorder, manifesting progressive motor dysfunction. PD is pathologically characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta, and the presence of intracellular inclusion bodies called Lewy bodies (LB) in the remaining neurons. As the most frequent PD-causing mutation in LRRK2, G2019S, increases the kinase activity of LRRK2, an abnormal increase in LRRK2 kinase activity is believed to contribute to PD pathology; however, the precise biological functions of LRRK2 involved in PD pathogenesis remain unknown. Although biochemical studies have discovered several substrate proteins of LRRK2 including Rab GTPases and tau, little is known about whether excess phosphorylation of these substrates is the cause of the neurodegeneration in PD. In this review, we summarize latest findings regarding the physiological and pathological functions of LRRK2, and discuss the possible molecular mechanisms of neurodegeneration caused by LRRK2 and its substrates.

Schlagwörter

Stichwörter der Autor:innen

Parkinsons diseaseleucine rich repeat kinaseneurodegenerationrab

Autor:innen und Institutionen

  • Laboratory of Neuropathology and Neuroscience, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
  • Laboratory of Brain and Neurological Disorders, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.

ORCID-Profile: Taisuke Tomita

Zitieren

APA

Araki, M., Ito, G., & Tomita, T. (2018). Physiological and pathological functions of LRRK2: implications from substrate proteins. Neuronal Signaling, 2(4). https://doi.org/10.1042/ns20180005

Vancouver

Araki M, Ito G, Tomita T. Physiological and pathological functions of LRRK2: implications from substrate proteins. Neuronal Signaling. 2018;2(4). doi:10.1042/ns20180005

BibTeX
@article{Araki2018,
  author = {Araki, Miho and Ito, Genta and Tomita, Taisuke},
  title = {Physiological and pathological functions of LRRK2: implications from substrate proteins},
  journal = {Neuronal Signaling},
  year = {2018},
  volume = {2},
  number = {4},
  doi = {10.1042/ns20180005}
}
Kostenlos starten →